Yingchang Mi Selected Research

Yingchang Mi Research Topics

Disease

16	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2022 - 03/2008
15	Leukemia 09/2021 - 03/2003
12	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 11/2009
7	Philadelphia Chromosome 01/2021 - 11/2014
4	Acute Promyelocytic Leukemia 12/2022 - 08/2014
4	Chromosome Aberrations (Chromosome Abnormalities) 06/2015 - 07/2009
2	Sepsis (Septicemia) 03/2022 - 12/2020
2	Genomic Instability 12/2021 - 09/2011
2	Infections 12/2020 - 01/2017
2	Cytokine Release Syndrome 10/2020 - 05/2020
2	Wilms Tumor (Wilm's Tumor) 09/2017 - 12/2014
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2014 - 07/2014
1	Hematologic Diseases (Blood Diseases) 03/2022
1	Bacteremia 03/2022
1	Invasive Fungal Infections 01/2022
1	Skin Neoplasms (Skin Cancer) 05/2020
1	Lymphoma (Lymphomas) 05/2020
1	Brain Diseases (Brain Disorder) 05/2020
1	Candidemia 01/2020
1	Genetic Translocation (Chromosomal Translocation) 12/2017
1	Neutropenia 01/2017
1	Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic) 04/2016
1	Mycoses (Diseases, Fungus) 01/2015
1	Pulmonary Arterial Hypertension 07/2014
1	Dyspnea (Shortness of Breath) 07/2014
1	Neoplasms (Cancer) 09/2011
1	Autoimmune Diseases (Autoimmune Disease) 03/2003

Drug/Important Bio-Agent (IBA)

7	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 03/2008
4	venetoclaxIBA 04/2022 - 09/2021
3	Dasatinib (BMS 354825)FDA Link 01/2021 - 07/2014
3	Chimeric Antigen ReceptorsIBA 10/2020 - 01/2020
3	Peroxidase (Myeloperoxidase)IBA 04/2016 - 12/2011
3	Imatinib Mesylate (Gleevec)FDA Link 09/2014 - 11/2009
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2022 - 03/2015
2	Cytokine Receptors (Cytokine Receptor)IBA 04/2018 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 09/2017 - 03/2003
2	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2016 - 03/2008
2	HomoharringtonineIBA 03/2015 - 03/2008
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 08/2012 - 10/2011
1	Arsenic Trioxide (Trisenox)FDA Link 12/2022
1	posaconazole FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Azacitidine (5 Azacytidine)FDA Link 09/2021
1	alanyl-leucyl-alanyl-leucine (ALAL)IBA 09/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2020
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 12/2020
1	QuinolonesIBA 12/2020
1	SteroidsIBA 10/2020
1	Janus KinasesIBA 10/2020
1	ruxolitinibIBA 10/2020
1	CytokinesIBA 10/2020
1	Antifungal AgentsIBA 01/2020
1	nilotinib FDA Link 03/2019
1	CBFbeta-MYH11 fusion proteinIBA 10/2018
1	Core Binding Factors (Core-Binding Factor)IBA 10/2018
1	Co-Repressor ProteinsIBA 04/2018
1	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	Pyridinolcarbamate (P23)IBA 12/2017
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 12/2017
1	Serine Proteases (Serine Protease)IBA 09/2017
1	HLA-DR Antigens (HLA-DR)IBA 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2016
1	AntigensIBA 06/2015
1	Caspofungin (Cancidas)FDA Link 01/2015
1	Biological ProductsIBA 12/2014
1	CateninsIBA 12/2014
1	AcidsIBA 08/2014
1	RetinoidsIBA 08/2014
1	Cadherins (E-Cadherin)IBA 05/2014
1	HeterochromatinIBA 02/2014
1	Arginine (L-Arginine)FDA Link 08/2012
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2011
1	DNA (Deoxyribonucleic Acid)IBA 08/2011
1	OligonucleotidesIBA 02/2011
1	Daunorubicin (Cerubidine)FDA LinkGeneric 03/2008
1	NucleolinIBA 03/2003
1	Poly (ADP-Ribose) Polymerase-1IBA 03/2003
1	AutoantibodiesIBA 03/2003

Therapy/Procedure

11	Therapeutics 03/2022 - 03/2008
7	Drug Therapy (Chemotherapy) 09/2021 - 11/2009
2	Induction Chemotherapy 01/2017 - 07/2009
2	Consolidation Chemotherapy 01/2017 - 03/2015
2	Transplantation 06/2015 - 05/2014
2	Hematopoietic Stem Cell Transplantation 06/2015 - 12/2014
1	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2020
1	Ligation 04/2018